Trial
NCT02592707
Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Ipsen
Collaborators
—
Condition
Neuroendocrine Tumors
Intervention
Satoreotide tetraxetan
Why stopped
Terminated (Due to small number of ongoing patients. Patients ongoing at time of termination could choose to join study D-FR-01072-004 for long term follow-up.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-07-19